Improving anticoagulation of patients with an implantable left ventricular assist device

Patients supported with implantable left ventricular assist devices (LVAD) have a significant risk of bleeding and thromboembolic complications. All patients require anticoagulation with warfarin, aiming for a target international normalised ratio (INR) of 2.5 and most patients also receive antiplat...

Descripción completa

Detalles Bibliográficos
Autores principales: Sage, William, Gottiparthy, Amulya, Lincoln, Paul, Tsui, Steven S L, Pettit, Stephen J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
BMJ Quality Improvement report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173227/
https://www.ncbi.nlm.nih.gov/pubmed/30306143
http://dx.doi.org/10.1136/bmjoq-2017-000250

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6173227/
https://www.ncbi.nlm.nih.gov/pubmed/30306143
http://dx.doi.org/10.1136/bmjoq-2017-000250

Ejemplares similares